Abstract
Prevalence of pulmonary arterial hypertension (PAH) was studied by Echocardiography and Doppler in 43 splenectomised patients with various disorders 1–20 years after splenectomy. PAH was detected only in thalassemia major, intermedia, hereditary sphereocytosis and myelofibrosis groups comprising a total of 21 patients. Six patients out of 21 was found to have PAH with mean pulmonary arterial pressure of 46.28 ± 28.17 mmHg. Twenty one controls having similar duration and type of disease also were assessed for PAH in this case control study 3/21 had PAH in this control group. The difference in number of patients showing pulmonary hypertension between case and control was not statistically significant (chi-square test p = 0.29-though the difference in pulmonary arterial pressure between case and control were significantly different (t-test p<0.0029) with control group showing a mean pulmonary arterial pressure of 25 ± 19 mmHg.
Platelet count in the splenectomised group was significantly higher (p = 0.0029) than the controls. Pulmonary thromboembolism was equally high in the PAH patients with and without splenectomy. Patients undergoing splenectomy due to trauma, immune thrombocytopenia, sideroblastic anemia, extra hepatic portal hypertension, autoimmune hemolytic anemia did not show PAH after splenectomy even years after the procedure PAH following splenectomy is common after certain disorders and control patients with these diseases have tendency to develop PAH even without splenectomy. Pulmonary thromboembolism may be an important pathophysiological mechanism leading to this condition. Patients having hemolytic anemia and myelofibrosis should have regular evaluation of pulmonary arterial pressure whether he/she has been splenectomised or not. This is particularly important as availability of phosphodiesterase inhibitors like sildenafil allows one to manage these cases.
Keywords: PAH, Splenectomy, Thalassemia major, Thalassemia intermedia, Myelofibrosis, Pulmonary thromboembolism
Full Text
The Full Text of this article is available as a PDF (159.5 KB).
References
- 1.Hoeper M.M., Niedermeyer J., Hoffmeyer F., Flemming P., Fa-bel H. Pulmonary hypertension after splenectomy? Ann Intern Med. 1999;16(131):793. doi: 10.7326/0003-4819-130-6-199903160-00014. [DOI] [PubMed] [Google Scholar]
- 2.Grisaru D, Rachmilewitz EA, Mosseri M, Gotsman M, La-fari JS, Okon E, Goldfarb A, Hasin Y (2004) Cunningham and Elliott Vichinsky; Cardiopulmonary assessment in beta thalassemia major. ASH Education Programme Book [DOI] [PubMed]
- 3.Athanasios A., Dimitrios F., Spyros D., Maria T., Stergious T., Ioannis M., Karagiorga M. Thalassemia heart disease. A comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005;127:1523–1530. doi: 10.1378/chest.127.5.1523. [DOI] [PubMed] [Google Scholar]
- 4.Atichartakarn V., Likittanasombat K., Chuncharunee S., Chan-danamattha P., Worapongpaiboon S., Angchaisuksiri P. Pulmonary arterial hypertension in previously splenecto-mized patients with beta thalassemia disorders. Int J Haematol. 2003;78:139–145. doi: 10.1007/BF02983382. [DOI] [PubMed] [Google Scholar]
- 5.Athanasios A., Dimitrios F., Markisia K., Ersi V., Aphrodite L., Antonia H., Jacqueline J., John R., Dimitris L. Cardiac involvement in thalassemia intermedia: a multicentre study. Blood. 2001;97:3411–3416. doi: 10.1182/blood.V97.11.3411. [DOI] [PubMed] [Google Scholar]
- 6.Athanasios A., Dimitrios F. Pulmonary hypertension in beta thalassemia. Ann NY Acad Sci. 2005;1054:342–349. doi: 10.1196/annals.1345.041. [DOI] [PubMed] [Google Scholar]
- 7.Jais X., Loos V., Jardim C., Siton O., Parent F., Hamid A., Fadel E., Dartevelle P., Simmonneau G., Humbert M. Splenec-tomy and chronic thromboembolic pulmonary hypertension. Thorax. 2005;60:1031–1034. doi: 10.1136/thx.2004.038083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Peacock A.J. Pulmonary hypetension after splenectomy: a consequence of loss of the splenic filter or is there something more? Thorax. 2005;60:983–984. doi: 10.1136/thx.2005.043216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kisanuki A., Kietthubthew S., Asada Y., Maruthsuka K., Fu-nahara Y., Sumiyoshi A. Intravenious injectionof sonicated blood induces pulmonary microthromboembolism in rabbits with ligation of the splenic artery. Thromb Res. 1997;85:95–103. doi: 10.1016/S0049-3848(96)00226-5. [DOI] [PubMed] [Google Scholar]
- 10.Chou R., DeLoughery T.G. Recurrent thromboembolic diseae following splenectomy for pyruvate kinase deficiency. Am J Haematol. 2001;67(3):197–199. doi: 10.1002/ajh.1107. [DOI] [PubMed] [Google Scholar]
- 11.Jardine D.L., Laing A.D. Delayed pulmonary hypertension following splenectomy for congenital spherocytosis. Intern Med J. 2004;34:214–216. doi: 10.1111/j.1444-0903.2004.00580.x. [DOI] [PubMed] [Google Scholar]
- 12.Morris Cr., Kuypers F.A., Kato G.J., Lavrisha L., Larkin S., Singer T., Vichinsky E.P. Hemolysis associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2005;1054:481–485. doi: 10.1196/annals.1345.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bidot C.J., Jy W., Horstman L.L., Ahn E.R., Yamiz M., Ahn Y.S. Anti phospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS) Am J Haematol. 2006;81:391–396. doi: 10.1002/ajh.20571. [DOI] [PubMed] [Google Scholar]
- 14.Eldor, Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood. 2002;99:36–43. doi: 10.1182/blood.V99.1.36. [DOI] [PubMed] [Google Scholar]
- 15.Sonakul D., Fucharoen S. Pulmonary thromboembolism in thalassemic patients. South East Asian J Trop Med Public Health. 1992;23:25–28. [PubMed] [Google Scholar]
- 16.Zetterberg E., Popat U., Hasselbalch H., Prchal J., Palmblad J. Angiogenesis in pulmonary hypertension with myelofibrosis. Haematologica. 2008;93:945–946. doi: 10.3324/haematol.12426. [DOI] [PubMed] [Google Scholar]
- 17.Fisher M.R., Forfia P.R., Chamera E., Housten-Harris T., Cham-pion H.C., Girgis R.E., Corretti M.C., Hassoun P.M. Accuracy of doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:615–621. doi: 10.1164/rccm.200811-1691OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Guazzi M., Vicenzi M., Samaja M. Clinical use of phosphodiesterase-5 inhibitors in cardiopulmonary diseases: from experimental evidence to clinical application. G Ital Cardiol (Rome) 2009;10:725–737. [PubMed] [Google Scholar]